In a transgenic mouse line hK14mIL33tg, with the expression of interleukin-33 (IL-33) driven by a keratin 14 promoter, keratoconjunctivitis developed spontaneously between 18 and 22 weeks of age under specific-pathogen-free conditions. These mice showed blepharitis and corneal impairments, and the histology revealed epithelial thickening in the conjunctiva and the cornea with infiltration of eosinophils, mast cells and basophils. IL-5, IL-13 and CCL11 were abundant in lacrimal fluid in the mice, and the gene expressions of IL-4, IL-5, IL-13, IL-33, Prg2 and Mmcp8 were significantly increased in the cornea. Furthermore, group 2 innate lymphoid cells (ILC2) producing IL-5 and IL-13 were markedly increased in the cornea. These phenotypes closely resemble human atopic keratoconjunctivitis (AKC). The characteristic ocular phenotype in these mice strongly suggests that IL-33 is crucial for the development of AKC. The mouse line may be useful as a novel model for research and development of therapeutic strategies for AKC.
Increased Th2 cytokines and chemokines in the lacrimal fluid of 20-to 30-week-old IL33tg mice. Cytokines and chemokines in the lacrimal fluid of IL33tg mice were examined using a protein array ( Fig. 3) . The concentration of IL-33 in the lacrimal fluid was much higher in IL33tg mice than in WT mice. IL-1α, IL-1β, IL-5, IL-6, IL-13, CCL2, CCL3, CCL5, CCL11, CXCL1 and G-CSF were also significantly higher in the lacrimal fluid of IL33tg mice (Fig. 3a) . On the other hand, Th1 cytokines such as IFN-γ, TNF-α and IL-12p70 were unaltered (Fig. 3b ). The lacrimal fluid cytokine and chemokine profile with the infiltration of eosinophils in IL33tg mice coincides with that of patients with AKC [17] [18] [19] . The infiltration of eosinophils in the lesions may be associated with Th2 cytokines and chemokines such as IL-5, IL-13, CCL5 and CCL11. 30- week-old IL33tg mouse conjunctiva and cornea. The gene expression of IL-33 and Th2 cytokines in mouse conjunctiva and cornea were examined using quantitative real-time polymerase chain reaction (qPCR). As shown in Fig. 4a , the expression of Il33 in the conjunctiva was significantly higher in IL33tg mice than in WT mice, and Il4, Il5, and Il13 were also significantly increased in the tissue of IL33tg mice versus that of WT mice. Eosinophil granule major basic protein (Prg2) is a marker for eosinophils; basophil-specific granzyme B-like protease (Mmcp8) is the first lineage-specific differentiation marker for mouse basophils. The gene expressions of Prg2 and Mmcp8 in the conjunctiva were also significantly higher in IL33tg mice than in WT mice.
Gene expression of Th2 cytokines and markers for eosinophils and basophils in 20-to
Similarly, the expressions of Il33, Il4, Il5, Il13, Prg2 and Mmcp8 were markedly increased in the corneas of IL33tg mice (Fig. 4b ). These results may reflect the infiltration of eosinophils and basophils in the ocular tissues of IL33tg mice.
Induction of ILC2 in 20-to 30-week-old IL33tg mouse cornea. Concentrations of IL-5 and IL-13
were abundant in the lacrimal fluid, and the gene expression of these cytokines in the cornea was strongly induced in IL33tg mice. This suggests that ILC2 increase ocular surface lesions, as these Th2 cytokines are massively produced by ILC2 4 . We next examined lineage-markers (Lin) − ST2 + Sca-1 + ILC2 in the cornea using flow cytometry ( Fig. 5a ). These corneal ILC2 cells were surface Thy1.2 + and intracellular GATA3 + . While ILC2 resided in the corneas of WT mice, these cells were more abundant in the corneas of IL33tg mice (Fig. 5b ). The proportion of ILC2 in the corneal cells was about 20 times greater in IL33tg mice than in WT mice. To determine the cells producing Th2 cytokines, corneal cell suspensions from IL33tg mice were subjected to intracellular staining for IL-5 and IL-13 ( Fig. 5c ). Lin − Sca-1 + ST2 + ILC2 from IL33tg mouse cornea expressed high levels of IL-5 and IL-13. Interestingly, IL-13-producing ILC2 cells also produced IL-5 ( Fig. 5d ). In addition, almost all cells expressing IL-5 or IL-13 were Lin − ST2 + Sca-1 + ILC2 ( Supplementary Fig. 2a,b ), and Lin + cells did not produce Th2 cytokines ( Supplementary Fig. 2a ). These results suggest that ILC2 are a major source for IL-5 and IL-13 in the lesional corneas of IL33tg mice.
Induction of basophils in 20-to 30-week-old IL33tg mouse cornea. The increase of Mmcp8, a marker for mouse basophils, in IL33tg mouse corneas prompted us to examine basophil infiltration in the cornea. Flow cytometry showed that DX5 + FcεRI + basophils were significantly increased in the corneal cells of IL33tg mice, compared with WT mice (Fig. 6a,b ). Immunohistochemistry revealed that mMCP-8 + basophils were abundant in the corneal stroma of IL33tg mice (Fig. 6c ).
Conjunctivitis precedes keratitis in IL33tg mice. Compared with WT mice, IL-33 was strongly positive in the nuclei of conjunctival ( Supplementary Fig. 3a ) and corneal ( Supplementary Fig. 3b ) epithelia in 8-to 10-week-old IL33tg mice. In these IL33tg mice, conjunctivitis with eosinophilic infiltration ( Supplementary  Fig. 3c ,e) was often evident, but keratitis was not observed ( Supplementary Fig. 3d ,f). The expressions of Il4, Il5, Il13, Il33, Prg2 and Mmcp8 were significantly increased in the conjunctiva ( Supplementary Fig. 4a ) in 10-week-old IL33tg mice versus WT mice, but not in the corneas ( Supplementary Fig. 4b ). These results suggest that conjunctivitis precedes keratitis in IL33tg mice.
The gene expressions of Il1b and Il6 were not increased in the conjunctiva and cornea of 10-week-old IL33tg ( Supplementary Fig. 4a ), in contrast with a significant increase in 20-to 30-week-old IL33tg mice versus WT mice ( Fig. 4a ). Although the reason for the induction of these genes is unknown, it may reflect epithelial thickening associated with inflammation.
Discussion
The K14 promoter is used for constitutive activation of genes in mainly stratified squamous epithelia, such as skin, parts of the respiratory, digestive and genital tracts, and ocular surface epithelium. We generated a transgenic mouse line, in which mouse IL-33 is overexpressed under the control of a K14 promoter, and characterized the skin phenotypes resembling AD 7 . We next focused on the ocular lesions spontaneously developed in the mice and elucidated the pathological effect of lifelong overexpression of IL-33 on conjunctiva and cornea.
In this study, we clearly demonstrate that the overexpression of IL-33 in conjunctival and corneal epithelia induces AKC-like inflammation in vivo. IL-33 is increased in the conjunctiva of AKC patients 13 , but the role of IL-33 in the pathogenesis of AKC had not been fully understood. Our present findings strongly suggest that IL-33 mediates the development of AKC.
Several mouse models for allergic conjunctivitis have been reported 10, 20, 21 , but an AKC model in which conjunctival inflammation extends to the cornea and keratitis develops had not been documented. In IL33tg mice, the infiltration of eosinophils, mast cells and basophils are evident in the conjunctival and corneal epithelia. This is comparable to the pathological findings in human AKC in which eosinophils 22, 23 , mast cells and basophils 21 infiltrate the conjunctiva and the corneal stroma.
We have shown that IL-33 activates mast cells in vitro 6 , mast cells accumulate in AD-like eruptions and serum IgE levels are high in IL33tg mice 7 . The phenotype of AKC-like lesions in IL33tg mice suggests that mast cells in keratoconjunctivitis are activated in response to IL-33, which is overexpressed in the ocular surface epithelium in vivo. The AKC lesions that develop spontaneously in IL33tg mice may be useful for research on the corneal inflammation associated with AD, since biopsy of the cornea is clinically difficult 23 and since the pathophysiology of corneal involvement remains to be addressed in human AKC tissues.
In AKC patients, cytotoxic proteins from eosinophils and proteases from mast cells are postulated to damage the corneal epithelium 23, 24 . Subsequently, IL-4 and IL-13 penetrate the damaged sites of the epithelium and activate keratocytes to produce cytokines and/or chemokines such as CCL11 25 . Possibly, those molecules further recruit eosinophils and mast cells in the cornea. Th2 cytokines are dominant in the lacrimal fluids of IL33tg mice, in contrast to Th1 cytokines (Fig. 3) . Previous reports showed increases in Th2 cytokines IL-5 18 and IL-13 19 . CCL11, a chemokine, is also increased in the lacrimal fluids of AKC patients, and the concentration is especially high in AKC with corneal erosions 17 . Thus, the cytokine and chemokine profile in lacrimal fluids of IL33tg mice is largely comparable with that reported in human AKC, although it is still controversial whether IFN-γ, a Th1 cytokine, is increased in lacrimal fluids of AKC patients 11, 18, 26 , and the cytokine was not increased in lacrimal fluids of IL33tg mice.
The number of patients with allergic conjunctival diseases peaks in the early twenties, and the incidence decreases with age by spontaneous regression 12 . However, Ono et al. 27 reported that AKC occurs more frequently between the ages of 30 and 50. The ocular surface inflammation in IL33tg mice does not subside with age, possibly because of sustained IL-33 expression in the epithelium, and therefore the keratoconjunctivitis occurred in IL33tg might be a chronic disease model for AKC. In the acquired immunity model of allergic conjunctivitis 10 , we showed that exogenous IL-33 activates ragweed pollen-specific Th2 cells. AKC is suggested to be a T cell-mediated disease 11, 12 . However, ILC2, like T cells (Th2 cells), may play a role in keratoconjunctivitis in IL33tg mice, as ILC2 can produce massive IL-5 and IL-13 in response to the stimulation of IL-33 4 , and those Th2 cytokines are produced by ILC2 in the corneas of IL33tg mice ( Supplementary Fig. 2 ). Interestingly, we found the presence of ILC2 in the intact corneas of WT mice (cornea-resident ILC2), but ILC2 were greater in the corneas of IL33tg mice (Fig. 5a,b) . Furthermore, IL-5 and IL-13 in the cornea are produced only by CD45 + Lin − Sca-1 + ST2 + ILC2 ( Supplementary Fig. 2 ). ILC2 residing naturally in peripheral tissues are now classified as "natural helper cells" or "natural ILC2 (nILC2)" 28 . They also have been identified in the lung respiratory epithelium 29 and in the skin 7 . The increased expression of basophil-specific Mmcp8 and the infiltration of basophils in the cornea were demonstrated in IL33tg mice. We have reported that excess IL-33 causes migration of basophils via induction of CCL2, CCL3 and CCL5 6 . We therefore speculate that these chemokines, which were significantly increased in lacrimal fluids, might be involved in the recruitment of basophils into the corneas of IL33tg mice.
Inflammatory events elicited by IL-33 in the conjunctiva and cornea in IL33tg mice may be a complex process involving basophils and ILC2 in concert with activation of Th2 cytokines/chemokines. Basophil-produced IL-4 influences not only the expression of Th2 cytokines and chemokines in ILC2, but the cellular expansion of ILC2 30 ; IL-33-stimulated ILC2 produce CCL5 and CCL11, facilitating the migration of basophils to inflamed tissue 6 . Thus, cytokine production and the accumulation of ILC2 and basophils can occur in the same phase of inflammation, and ILC2 and basophils accumulate in close proximity to each other 31 .
The characteristic ocular phenotype of IL33tg mice strongly suggests that IL-33 is crucial for the development of AKC. Epithelial IL-33 might stimulate resident-ILC2 and proliferates and activates ILC2-producing IL-5, IL-13 and chemokines, and thereby induce inflammatory processes in the conjunctiva and the cornea with eosinophils, basophils and mast cells. However, further studies are required to understand the mechanisms for AKC. As a novel mouse model for AKC with corneal impairment, IL33tg mice may be useful in research on corneal involvement in AKC and for the development of new therapeutic approaches to AKC.
Methods
Mice. All studies involving animals were reviewed and approved by the Animal Use and Care Committee of the Hyogo College of Medicine and were designed in accordance with the International Guiding Principles for Biomedical Research Involving Animals published by the Council for the International Organization of Medical Science. The mouse line hK14mIL33tg was generated and grown as described previously 7 . All mice used in this study were maintained under SPF conditions. Materials. Fluorescence-labeled antibodies for Siglec-F were purchased from BD Biosciences (San Jose, CA); those for B220, CD3, CD4, CD8, CD45, DX5, Gr-1, NK1.1, Sca-1, Thy-1.2 and IL-5 (TRFK5) were from BioLegend (San Diego, CA); those for FcεR1 (MAR-1), GATA3 (TWAJ), IL-13 (eBio13A) and Rat IgG1 (eBRG1), control antibody, were from e-Biosciences (San Diego, CA). Fluorescence-labeled antibody for ST2 (DJ8) was from MD Biosciences (St Paul, MN). For corneal fluorescein staining, Fluores ® ocular examination test papers (Showa Yakuhin Kako, Tokyo, Japan) were used according to the manufacturer's instructions.
Preparation of mouse conjunctiva and cornea. Dr. Yuka Hosotani and Dr. Hiroto Ishikawa, certified ophthalmic surgeons at Hyogo College of Medicine Hospital, prepared mouse ocular specimens under the microscope (Zeiss Stemi 2000-C stereo microscope). Ocular tissues were dissected using micro-scissors and forceps, a full thickness of the cornea was separated using a 2.0-mm trephine (Inami, Toyo, Japan), and conjunctiva was carefully separated from surrounding sclera and palpebra. These specimens were used for gene expression assay and flow cytometry. Flow Cytometry. Cell suspensions from mouse tissue were prepared as described previously 7 . The method was modified as follows for corneal cells: Homogenized corneal sheets were incubated in 4 ml RPMI 1640 containing 1% fetal calf serum, 85 µg/ml Liberase TM (Roche, Basel, Switzerland) and 0.01% DNase I (Roche) at 37 °C for 60 min. Cells were stained with each antibody and were examined using a flow cytometer LSRFortessa (BD Biosciences) or LE-SP6800Z (Sony, Tokyo, Japan). The classification of cells is as follows: Lineage-markers (B220, CD3, CD4, CD8, Gr-1, NK1.1, Siglec-F, DX5, FcεRI) − CD45 + Sca-1 + ST2 + cells: ILC2 cells. B220 − CD3 − CD4 − CD8 − Gr-1 − NK1.1 − Siglec-F − CD45 + DX5 + FcεRI + cells: basophils. For intracellular cytokine staining, cornea cells were incubated in culture medium for 4 h in the presence of monensin with phorbol 12-myristate 13-acetate/ionomycin, and then surface antigens were stained in the presence of monensin. Following the fixation and permeabilization of the cells using a Fixation and Permeabilization Solution Kit (BD Biosciences), cells were stained with anti-IL-5, IL-13 or control rat IgG1 antibody. For intracellular GATA3 staining, cornea cells were stained using the Foxp3/Transcription Factor Staining Buffer Set (e-Biosciences, cat 00-5523). 
